Hemophilia Clinical Scientist Development Grantees
2014-2019 Grantees
Robert F. Sidonio Jr, MD MSc
Assistant Professor of Pediatrics
Vanderbilt University Medical Center, Nashville, Tennessee
Area of Research: Prospective Feasibility Study of the Bleeding Genotype and Phenotype in Hemophilia A Carriers
Sean R. Stowell MD PhD
Post-Doctoral Fellow
Emory University, Atlanta
Area of Research: Characterization of Factors Influencing the Development of Factor VIII Inhibitors
2013–2018 Grantee
Trinh Nguyen of the University, D.O.
Texas Health Science Center
Area of Research: Proper dosing of factor VIII in obese/overweight people with hemophilia A
2010–2015 Grantee
Jordan Shavit, M.D., Ph.D.
University of Michigan, Ann Arbor, Michigan
Area of Research: Novel methods for the identification of genetic and chemical modifiers of hemophilia
2008–2013 Grantees
Michael Callaghan, M.D.
Wayne State University, Detroit, Michigan
Area of Research: Exploiting the Unfolded Protein Response to Eliminate Inhibitor Antibodies in Hemophilia A
Shannon Meeks, M.D.
Emory University, Atlanta, Georgia
Area of Research: Mechanisms of Immunogenicity of Factor VIII in a Model Antigen System
2005–2010 Grantees
Amy L. Dunn, M.D.
Emory University, Atlanta, Georgia
Area of research: Blood Induced Cartilage Changes in a Hemophilia A Murine Model
Miguel A. Escobar, M.D.
University of Texas Health Science Center at Houston
Area of research: Covalent Inactivation of Antibodies to Factor VIII
2003–2008 Grantees
Suchitra S. Acharya, M.D.
Weill Medical College of Cornell University, New York, New York
Area of research: Angiogenesis and Hemophilia Synovitis
Paul E. Monahan, M.D.
University of North Carolina at Chapel Hill
Area of research: Overcoming Limited Clotting Factor Gene Transfer to the Liver Using Adeno-associated Virus (AAV) Vectors Presenting a More Active Molecular Form
Mark T. Reding, M.D.
University of Minnesota, Minneapolis
Area of research: Immune Response to Factor VIII Following Gene Therapy With Blood Outgrowth Endothelial Cells (BOEC)